Patients With Myelodysplastic Syndromes Benefit From Therapy With Amifostine Pentoxifylline and Ciprofloxacin With Dexamethasone.

Turken, OrhanOrhan, BetülÖztürk, AhmetEtiz, DurmuşYaylacı, MustafaUskent, NecdetCore Program07. Core Program01. Kadir Has University2019-06-272019-06-2720010006-49710006-4971https://hdl.handle.net/20.500.12469/232[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessPatients With Myelodysplastic Syndromes Benefit From Therapy With Amifostine Pentoxifylline and Ciprofloxacin With Dexamethasone.Conference Object0